BioGend Therapeutics Co., Ltd. (TPEX:6733)

Taiwan · Delayed Price · Currency is TWD

24.40

+0.20 (0.83%)

Oct 16, 2026, 1:09 PM CST

BioGend Therapeutics Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	3,277	4,775	4,181	4,708	2,247	2,757
Market Cap Growth	-40.33%	14.21%	-11.18%	109.50%	-18.50%	-22.86%
Enterprise Value	2,445	4,269	3,558	3,990	1,720	2,063
Last Close Price	24.40	38.28	33.55	38.13	21.73	26.32

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	13.85	21.48	24.94	42.83	71.46	297.47
PB Ratio	3.04	6.30	4.94	4.92	3.07	2.92
P/TBV Ratio	3.29	7.33	6.09	6.09	4.73	4.53

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	10.33	19.20	21.22	36.30	54.70	222.54

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.00	0.01	0.01	0.01	0.02	0.01
Net Debt / Equity Ratio	-0.78	-0.67	-0.72	-0.74	-0.65	-0.73
Net Debt / EBITDA Ratio	18.28	7.94	8.15	5.68	2.80	4.97
Net Debt / FCF Ratio	16.85	7.80	6.12	4.32	2.56	4.98
Asset Turnover	0.24	0.26	0.17	0.12	0.03	0.01
Inventory Turnover	3.16	3.41	2.29	1.89	1.24	0.64
Quick Ratio	31.12	16.84	21.06	16.90	16.73	28.58
Current Ratio	32.13	17.60	21.60	17.32	17.01	29.24
Return on Equity (ROE)	-8.17%	-11.88%	-13.30%	-19.07%	-24.54%	-17.51%
Return on Assets (ROA)	-5.83%	-7.99%	-7.78%	-11.79%	-14.85%	-11.74%
Return on Capital Employed (ROCE)	-8.40%	-14.20%	-13.90%	-17.60%	-27.70%	-16.50%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-2.07%	-1.77%	-2.79%	-3.32%	-8.21%	-5.02%
FCF Yield	-1.53%	-1.37%	-2.38%	-3.50%	-8.32%	-4.99%
Buyback Yield / Dilution	-1.75%	-	-2.32%	-16.69%	-1.77%	-15.90%